情景记忆
阿尔茨海默病
听力学
心理学
记忆障碍
医学
神经科学
精神科
肿瘤科
临床心理学
内科学
疾病
认知
作者
Alefiya Dhilla Albers,Josephine Asafu‐Adjei,Mary K. Delaney,Kathleen Kelly,Teresa Gómez‐Isla,Deborah Blacker,Keith A. Johnson,Reisa A. Sperling,Bradley T. Hyman,Rebecca A. Betensky,Lloyd Hastings,Mark W. Albers
摘要
Objective The objective of this study was to relate a novel test of identifying and recalling odor percepts to biomarkers of Alzheimer's disease (AD) in well‐characterized elderly individuals, ranging from cognitively normal to demented. Methods One hundred eighty‐three participants (cognitively normal: n = 70; subjective cognitive concerns: n = 74; mild cognitive impairment [MCI]: n = 29, AD dementia: n = 10) were administered novel olfactory tests: the Odor Percept IDentification (OPID) and the Percepts of Odor Episodic Memory (POEM) tests. Univariate cross‐sectional analyses of performance across diagnoses; logistic regression modeling, including covariates of age, sex, education, APOE genotype, and neuropsychological test scores; and linear mixed modeling of longitudinal cognitive scores were performed. Amyloid deposition and MRI volumetrics were analyzed in a subset of participants. Results Accuracy of identification and episodic memory of odor percepts differed significantly across diagnosis and age, with progressively worse performance across degrees of impairment. Among the participants who were cognitively normal or had subjective cognitive concerns, poorer than expected performance on the POEM test (based on the same individual's performance on the OPID and odor discrimination tests) was associated with higher frequencies of the APOE ε4 allele, thinner entorhinal cortices, and worse longitudinal trajectory of Logical Memory scores. Interpretation Selective impairment of episodic memory of odor percepts, relative to identification and discrimination of odor percepts revealed by this novel POEM battery, is associated with biomarkers of AD in a well‐characterized pre‐MCI population. These affordable, noninvasive olfactory tests offer potential to identify clinically normal individuals who have greater likelihood of future cognitive decline. Ann Neurol 2016;80:846–857
科研通智能强力驱动
Strongly Powered by AbleSci AI